[go: up one dir, main page]

MA24586A1 - Formes posologiques de sertraline et procede par leur preparation. - Google Patents

Formes posologiques de sertraline et procede par leur preparation.

Info

Publication number
MA24586A1
MA24586A1 MA25145A MA25145A MA24586A1 MA 24586 A1 MA24586 A1 MA 24586A1 MA 25145 A MA25145 A MA 25145A MA 25145 A MA25145 A MA 25145A MA 24586 A1 MA24586 A1 MA 24586A1
Authority
MA
Morocco
Prior art keywords
sertraline
preparation
dosage forms
dosage
forms
Prior art date
Application number
MA25145A
Other languages
English (en)
Inventor
Mysore Shanker Ravi
John Curatolo William
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA24586(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA24586A1 publication Critical patent/MA24586A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MA25145A 1997-07-01 1998-06-30 Formes posologiques de sertraline et procede par leur preparation. MA24586A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
MA24586A1 true MA24586A1 (fr) 1998-12-31

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25145A MA24586A1 (fr) 1997-07-01 1998-06-30 Formes posologiques de sertraline et procede par leur preparation.

Country Status (40)

Country Link
EP (1) EP0980241B1 (fr)
JP (1) JP3585245B2 (fr)
KR (1) KR100371730B1 (fr)
CN (1) CN1261792A (fr)
AP (1) AP945A (fr)
AR (1) AR015916A1 (fr)
AT (1) ATE256457T1 (fr)
AU (1) AU724635B2 (fr)
BG (1) BG103917A (fr)
BR (1) BR9809712A (fr)
CA (1) CA2290973C (fr)
CO (1) CO4940405A1 (fr)
DE (1) DE69820608T2 (fr)
DK (1) DK0980241T3 (fr)
DZ (1) DZ2544A1 (fr)
EA (1) EA001905B1 (fr)
ES (1) ES2210760T3 (fr)
GT (1) GT199800090A (fr)
HR (1) HRP980378B1 (fr)
HU (1) HUP0002250A3 (fr)
ID (1) ID24673A (fr)
IL (1) IL133075A0 (fr)
IS (1) IS5266A (fr)
MA (1) MA24586A1 (fr)
MY (1) MY119728A (fr)
NO (1) NO996492L (fr)
NZ (1) NZ501252A (fr)
OA (1) OA11246A (fr)
PA (1) PA8454001A1 (fr)
PE (1) PE97299A1 (fr)
PL (1) PL337807A1 (fr)
PT (1) PT980241E (fr)
SK (1) SK282914B6 (fr)
TN (1) TNSN98123A1 (fr)
TR (1) TR199903282T2 (fr)
TW (1) TW382597B (fr)
UA (1) UA68350C2 (fr)
UY (1) UY25070A1 (fr)
WO (1) WO1999001113A1 (fr)
ZA (1) ZA985709B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL348119A1 (en) * 1998-10-13 2002-05-06 Pfizer Prod Inc Sertraline oral concentrate
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
DE60026146T2 (de) 1999-09-03 2006-08-17 Apbi Holdings, Llc Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
CA2420535A1 (fr) 2000-08-30 2002-03-07 Mary Tanya Am Ende Formulations a liberation prolongee pour les secretagogues de l'hormone de croissance
EP1375659A1 (fr) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Mélanges concentrés dans des capsules solubles pour la préparation facilitée de solutions chimiques ou biologiques
EP1556000A1 (fr) * 2002-10-31 2005-07-27 Alza Corporation Formulation pharmaceutique permettant d'augmenter la biodisponibilite de medicaments hydrophobes
WO2016020936A2 (fr) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal Nouvelle forme posologique pharmaceutique orale de rétention gastrique
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
GB2630572A (en) 2023-05-29 2024-12-04 Novumgen Ltd An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69525847T2 (de) * 1994-09-19 2002-09-05 Dupont Pharmaceuticals Co., Wilmington Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
DE69626916T2 (de) * 1995-07-17 2003-10-09 Pfizer Inc., New York Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten

Also Published As

Publication number Publication date
KR20010013588A (fr) 2001-02-26
OA11246A (en) 2002-11-19
EP0980241A1 (fr) 2000-02-23
NO996492L (no) 2000-02-29
HRP980378B1 (en) 2001-12-31
PE97299A1 (es) 1999-10-13
IL133075A0 (en) 2001-03-19
HUP0002250A2 (hu) 2000-12-28
UA68350C2 (en) 2004-08-16
JP2000512316A (ja) 2000-09-19
HRP980378A2 (en) 1999-04-30
PL337807A1 (en) 2000-09-11
TNSN98123A1 (fr) 2005-03-15
EA001905B1 (ru) 2001-10-22
EP0980241B1 (fr) 2003-12-17
AP945A (en) 2001-02-28
TR199903282T2 (xx) 2000-08-21
CA2290973A1 (fr) 1999-01-14
KR100371730B1 (ko) 2003-02-07
DE69820608D1 (de) 2004-01-29
TW382597B (en) 2000-02-21
HUP0002250A3 (en) 2001-01-29
EA199900963A1 (ru) 2000-08-28
AU724635B2 (en) 2000-09-28
BR9809712A (pt) 2000-07-11
ID24673A (id) 2000-07-27
DZ2544A1 (fr) 2003-02-08
NZ501252A (en) 2004-11-26
AR015916A1 (es) 2001-05-30
ZA985709B (en) 2000-01-10
ES2210760T3 (es) 2004-07-01
PT980241E (pt) 2004-03-31
JP3585245B2 (ja) 2004-11-04
BG103917A (bg) 2000-07-31
ATE256457T1 (de) 2004-01-15
SK282914B6 (sk) 2003-01-09
NO996492D0 (no) 1999-12-27
DK0980241T3 (da) 2004-04-05
IS5266A (is) 1999-11-23
CO4940405A1 (es) 2000-07-24
CN1261792A (zh) 2000-08-02
AP9801279A0 (en) 1998-06-30
CA2290973C (fr) 2003-06-17
PA8454001A1 (es) 2000-05-24
MY119728A (en) 2005-07-29
UY25070A1 (es) 2000-12-29
GT199800090A (es) 1999-12-21
SK180599A3 (en) 2001-01-18
DE69820608T2 (de) 2004-12-23
AU7545098A (en) 1999-01-25
WO1999001113A1 (fr) 1999-01-14

Similar Documents

Publication Publication Date Title
DZ2546A1 (fr) Sels de sertraline et formes posologiques de sertraline à libération prolongée et procédé pour leur préparation.
FR2722984B1 (fr) Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
DE69710095D1 (de) Pharmazeutische zubereitung zur behandlung von diabetes
FR2758459B1 (fr) Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2748026B1 (fr) Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA26508A1 (fr) Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
MA26536A1 (fr) Association de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation.
FR13C0008I2 (fr) Derives de phosphonocephem, leur procede de preparation et leur utilisation
FR2772617B1 (fr) Comprime de progesterone et son procede de preparation
EE03767B1 (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
EP1014972A4 (fr) Procede de traitement et composition pharmaceutique
FR2722210B1 (fr) Nouvelles streptogramines et procede de preparation de streptogramines par mutasynthese
PT908458E (pt) Piridilmetilpiperazina substituida e derivados piperidina, sua preparacao e utilizacao para tratar as doencas do sistema nervoso central (cns)
MA24586A1 (fr) Formes posologiques de sertraline et procede par leur preparation.
DZ2078A1 (fr) Nouveaux médicaments hormonaux et leur utilisationpour la correction des carences estrogéniques.
DZ2547A1 (fr) Formes posologiques de sertraline à libération prolongée.
EP1023250A4 (fr) Procede de preparation de 2,6-dialkylnaphtalene
BR9607626A (pt) Novos compostos farmacéuticos de naftila
EP0895984A4 (fr) Polyamines alicycliques et leur procede de preparation
EP0890599A4 (fr) Polyorganosiloxazanes et leur procede de preparation
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
PT939083E (pt) Complexos de ferro-succinilcaseina procedimento para sua preparacao e suas composicoes farmaceuticas
FR2768725B1 (fr) Procede de preparation du 2-chloroprop-1-ene
HUP9904173A3 (en) Pharmaceutical composition for treating viral diseases
EP0823904A4 (fr) Procede de preparation de spiroindolines